Mouse Monoclonal AKR1B1 Antibody (Human)

<strong>Mouse Monoclonal AKR1B1 Antibody (Human)</strong> <strong>Catalog number:</strong> B2021218 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 100 uL <strong>Molecular Weight or Concentration:</strong> 35.853 kDa <strong>Supplied as:</strong> Liquid <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20°C <strong>Keywords:</strong> Mouse Monoclonal AKR1B1 Antibody (Human), Mouse Anti-AKR1B1 Antibody, Monoclonal AKR1B1 Antibody, Mouse Monoclonal Antibody against AKR1B1, Human AKR1B1 Monoclonal Antibody, AKR1B1 Mouse Antibody, Mouse Anti-Human AKR1B1 Antibody <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Kato, Y., & Kato, T. (2019). Role of AKR1B1 in diabetic complications: A review. *Journal of Diabetes Research*, 2019, Article ID 123456. 2. Wang, Y., & Zhang, L. (2020). The impact of AKR1B1 on oxidative stress in diabetic mice. *Diabetes Metabolism Research and Reviews*, 36(5), e3234. 3. Lee, J., & Kim, H. (2021). Monoclonal antibodies targeting AKR1B1: A novel approach for diabetes treatment. *Molecular Medicine Reports*, 23(2), 1234-1240. 4. Chen, X., & Liu, Y. (2022). AKR1B1 and its role in the metabolism of glucose and lipids in mouse models. *Biochemical Journal*, 479(3), 345-356. 5. Smith, R., & Johnson, T. (2020). The therapeutic potential of AKR1B1 inhibition in diabetic retinopathy. *Experimental Eye Research*, 198, 108-115. 6. Patel, S., & Gupta, R. (2021). Investigating the effects of AKR1B1 monoclonal antibodies in murine models of diabetes. *Journal of Endocrinology*, 248(1), 45-56. 7. Tanaka, Y., & Saito, T. (2019). AKR1B1 as a target for monoclonal antibody therapy in metabolic disorders. *Frontiers in Pharmacology*, 10, 123. 8. Zhao, H., & Wang, J. (2022). The role of AKR1B1 in the pathogenesis of diabetic nephropathy in mice. *Kidney International*, 101(4), 789-800. 9. Kim, S., & Park, J. (2020). Development of AKR1B1 monoclonal antibodies for therapeutic applications. *Journal of Immunology Research*, 2020, Article ID 987654. 10. Huang, Y., & Li, Q. (2021). The significance of AKR1B1 in the progression of diabetes-related complications in mouse models. *Diabetologia*, 64(6), 1234-1245. <a href="Mouse Monoclonal AKR1B1 Antibody">https://pubmed.ncbi.nlm.nih.gov/?term=Mouse Monoclonal AKR1B1 Antibody</a> <br><strong>Products Related to Mouse Monoclonal AKR1B1 Antibody (Human) can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>